TRPV1 and noise induced hearing loss: Since extracellular signal-regulated kinase (ERK) activation contributes to the pathology of NIHL (Meltser et al., 2010; Maeda et al., 2013), we tested the involvement of this kinase in TRPV1-mediated Ca2+ influx by pre-treating the ERK inhibitor, PD98059.